Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Amortization of Deferred Charges (2021 - 2025)

Historic Amortization of Deferred Charges for MDxHealth (MDXH) over the last 4 years, with Q3 2025 value amounting to -$923000.0.

  • MDxHealth's Amortization of Deferred Charges fell 21827.59% to -$923000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$482000.0, marking a year-over-year increase of 3682.83%. This contributed to the annual value of $286000.0 for FY2024, which is 3206.65% down from last year.
  • Per MDxHealth's latest filing, its Amortization of Deferred Charges stood at -$923000.0 for Q3 2025, which was down 21827.59% from -$549000.0 recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Amortization of Deferred Charges registered a high of $619000.0 during Q1 2025, and its lowest value of -$923000.0 during Q3 2025.
  • Its 4-year average for Amortization of Deferred Charges is -$174444.4, with a median of -$290000.0 in 2024.
  • As far as peak fluctuations go, MDxHealth's Amortization of Deferred Charges crashed by 11292.31% in 2022, and later plummeted by 21827.59% in 2025.
  • Over the past 4 years, MDxHealth's Amortization of Deferred Charges (Quarter) stood at -$325000.0 in 2021, then tumbled by 112.92% to -$692000.0 in 2022, then soared by 153.61% to $371000.0 in 2024, then crashed by 348.79% to -$923000.0 in 2025.
  • Its last three reported values are -$923000.0 in Q3 2025, -$549000.0 for Q2 2025, and $619000.0 during Q1 2025.